SECOND SIGHT MED PRODS INC - COM (EYES)

CUSIP: 81362J100

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / COM
Total 13F shares
7,125,324
Share change
-530,111
Total reported value
$13,681,533
Put/Call ratio
0.93%
Price per share
$1.92
Number of holders
38
Value change
-$1,011,650
Number of buys
17
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 81362J100?
CUSIP 81362J100 identifies EYES - SECOND SIGHT MED PRODS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SECOND SIGHT MED PRODS INC - COM (EYES) as of Q1 2018

As of 31 Mar 2018, SECOND SIGHT MED PRODS INC - COM (EYES) was held by 38 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,125,324 shares. The largest 10 holders included Versant Venture Management, LLC, VANGUARD GROUP INC, BlackRock Inc., Psagot Investment House Ltd., Sigma Planning Corp, GEODE CAPITAL MANAGEMENT, LLC, HBK Sorce Advisory LLC, Balyasny Asset Management LLC, Glassman Wealth Services, and ORACLE INVESTMENT MANAGEMENT INC. This page lists 38 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.